VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues

References

• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653–660
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–676
   PubMed Web of Science ®Google Scholar
• Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 2000; 96: 546–553
   PubMedGoogle Scholar
• Witmer A N, van Blijswijk B C, Dai J, Hofman P, Partanen T A, Vrensen G F, et al. VEGFR-3 in adult angiogenesis. J Pathol 2001; 195: 490–497
   PubMed Web of Science ®Google Scholar
• Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999; 154: 1381–1390
   PubMed Web of Science ®Google Scholar
• Le Bras B, Barallobre M J, Homman-Ludiye J, Ny A, Wyns S, Tammela T, et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci 2006; 9: 340–348
   PubMed Web of Science ®Google Scholar
• Garces C A, Kurenova E V, Golubovskaya V M, Cance W G. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res 2006; 66: 1446–1454
   PubMed Web of Science ®Google Scholar
• Orlandini M, Spreafico A, Bardelli M, Rocchigiani M, Salameh A, Nucciotti S, et al. Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem 2006; 281: 17961–17967
   PubMed Web of Science ®Google Scholar
• Scavelli C, Vacca A, Di Pietro G, Domacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004; 18: 1054–1058
   PubMed Web of Science ®Google Scholar
• Hussong J W, Perkins S L, Huff V, McDonald J M, Pysher T J, Beckwith J B, et al. Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis. Pediatr Dev Pathol 2000; 3: 561–567
   PubMed Web of Science ®Google Scholar
• Perez-Atayde A R, Sallan S E, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815–821
   PubMed Web of Science ®Google Scholar
• Dominici M, Campioni D, Lanza F, Luppi M, Barozzi P, Pauli S, et al. Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. Leukemia 2001; 15: 171–176
   PubMed Web of Science ®Google Scholar
• Moehler T M, Ho A D, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol 2003; 45: 227–244
   PubMed Web of Science ®Google Scholar
• Koster A, Raemaekers J M. Angiogenesis in malignant lymphomas. Curr Opin Oncol 2005; 17: 611–616
   PubMed Web of Science ®Google Scholar
• Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–1875
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995; 20: 27–38
   PubMed Web of Science ®Google Scholar
• Tzankov A, Heiss S, Ebner S, Sterlocci W, Schaefer G, Augustin F, et al. Angiogenesis in nodal B-cell lymphomas: a high throughput study. J Clin Pathol 2007; 60: 476–482
   PubMed Web of Science ®Google Scholar
• Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245
   PubMed Web of Science ®Google Scholar
• Ridell B, Norrby K. Intratumoral microvascular density in malignant lymphomas of B-cell origin. Apmis 2001; 109: 66–72
   PubMed Web of Science ®Google Scholar
• Lundberg L G, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15–19
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503–508
   PubMed Web of Science ®Google Scholar
• Dias S, Choy M, Alitalo K, Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 2002; 99: 2179–2184
   PubMed Web of Science ®Google Scholar
• Kay N E. The angiogenic status of B-CLL B cells: role of the VEGF receptors. Leuk Res 2004; 28: 221–222
   PubMed Web of Science ®Google Scholar
• Krauth M T, Simonitsch I, Aichberger K J, Mayerhofer M, Sperr W R, Sillaber C, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Am J Clin Pathol 2004; 121: 473–481
   PubMed Web of Science ®Google Scholar
• Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res 2004; 28: 243–248
   PubMed Web of Science ®Google Scholar
• Chen H, Treweeke A T, West D C, Till K J, Cawley J C, Zuzel M, et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 2000; 96: 3181–3187
   PubMed Web of Science ®Google Scholar
• Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F, et al. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenensiis and growth in Multiple Mieloma. Haemathologica 2003; 88: 176–185
   PubMed Web of Science ®Google Scholar
• Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette P S, Skobe M, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006; 24: 203–215
   PubMed Web of Science ®Google Scholar
• Fielder W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 1997; 11: 1234–1237
   PubMed Web of Science ®Google Scholar
• Salameh A, Galvagni F, Bardelli M, Bussolino F, Oliviero S. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood 2005; 106: 3423–3431
   PubMedGoogle Scholar
• Orlandini M, Semboloni S, Oliviero S. Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem 2003; 278: 44650–44656
   PubMed Web of Science ®Google Scholar
• J W Vardiman. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
   Google Scholar
• Lazzi S, Bellan C, Tiacci E, Palummo N, Oggioni M, et al. IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. J Pathol 2006; 209(1)56–66
   PubMed Web of Science ®Google Scholar
• Kvasnicka H M, Thiele J. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. Histol Histopathol 2004; 19: 1245–1260
   PubMed Web of Science ®Google Scholar
• Hiramatsu A, Miwa H, Shikomi M, Ikai T, Tajima E, Yamamoto H, et al. Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML. Leuk Lymhpoma 2006; 47: 89–95
   PubMed Web of Science ®Google Scholar